[go: up one dir, main page]

KR890700117A - 유효성분으로서 칼콘 유도체를 함유하는 항 궤양제 및 신규의 칼콘 유도체 - Google Patents

유효성분으로서 칼콘 유도체를 함유하는 항 궤양제 및 신규의 칼콘 유도체

Info

Publication number
KR890700117A
KR890700117A KR1019880700971A KR880700971A KR890700117A KR 890700117 A KR890700117 A KR 890700117A KR 1019880700971 A KR1019880700971 A KR 1019880700971A KR 880700971 A KR880700971 A KR 880700971A KR 890700117 A KR890700117 A KR 890700117A
Authority
KR
South Korea
Prior art keywords
propanone
carboxymethoxy
group
isopentylphenyl
methoxyphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019880700971A
Other languages
English (en)
Inventor
고마자와 유끼오
다께다 시게후미
호사까 구니오
와따나베 도시히꼬
Original Assignee
쓰무라 아끼라
쓰무라 준펜도 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP29495286A external-priority patent/JPS63150241A/ja
Priority claimed from JP19819787A external-priority patent/JPS6442422A/ja
Application filed by 쓰무라 아끼라, 쓰무라 준펜도 인코포레이티드 filed Critical 쓰무라 아끼라
Publication of KR890700117A publication Critical patent/KR890700117A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/90Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/62Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by hydrogenation of carbon-to-carbon double or triple bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/74Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/83Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups polycyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/835Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups having unsaturation outside an aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

내용 없음

Description

유효성분으로서 칼콘 유도체를 함유하는 항 궤양제 및 신규의 칼콘 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 유효성분으로서 다음의 일반식(Ⅰ)의 화합물을 함유하는 항궤양제
    상기 일반식중, X 및 Y는 각각 수소원자를 나타내거나 함께 단일결합을 형성하고, R'1은 히드록실기, 아세톡시기, 카르복시메톡시기 또는 메톡시카르보닐메톡시기를 나타내고, R'2는 수소원자, 이소프레닐기, 이소펜틸기 또는 프로필기를 나타내며, R'3은 히드록실기 또는 메톡시기를 나타내고, R'4는 수소원자, 히드록실기 또는 메톡시기를 나타내고, R'5는 수소원자, 히드록실기, 메톡시기 또는 이소펜틸기를 R'6은 히드록실기, 메톡시기 또는 카르복시메톡시기를 나타내며, R'7은 수소원자 또는 메톡시기를 나타낸다.
  2. 제1항에 있어서, 1-(2, 4, 6-트리히드록시-3-이소펜틸페닐-3-(4-히드록시-3-메톡시페닐)-1-프로판온, 1-(2, 4,6-트리히드록시-3-이소펜틸페닐)-3-(4-히드록시-3, 5-디메톡시페닐)-1-프로판온, 1-(2-카로복시메톡시-4-메톡시-3-이소펜틸페닐)-3-(4-메톡시페닐)-1-프로판온, 1-(2-히드록시-4-메톡시-3-이소펜틸페닐_-3(4-카르복시메톡시페닐)-1-프로판온, 1,(2-카르복시-메톡시-4,6-디메톡시-3-이소펜틸페닐)-3-(4-히드록시-3-메톡시페닐)-1-프로판온, 1-(2-카르복시메톡시-4,6-디메톡시-3-이소펜틸페닐)-3,(3-히드록시-4-메톡시페닐)-1-프로판온, 1-(2-카르복시메톡시-4,6-디메톡시-3-이소펜틸페닐) -3-(4-히드록시-3,5-디메톡시페닐)-1-프로판온, 2'-카르복시메톡시-4, 4 -디메톡시-3 -(3-메틸-2-부테닐)칼콘, 2 -카르복시메톡시-4, 4 , 6 -트리메톡시-3 -이소펜틸칼콘, 3-(4-히드록시페닐)-1-(2, 4, 6-트리히드록시-3-n-프로필페닐)-1-프로판온 1-(2-카르복시메톡시-4, 6-디메톡시페닐)-3-(4-메톡시페닐)-1-프로판온, 1-[2-카르복시메톡시-4, 6-디메톡시-3-(3-메틸-2-부테닐)페닐]-3-(4-메톡시페닐)-1-프로판온,2 -카르복시메톡시-4, 4 , 6 -트리메톡시칼콘, 2 -카르복시메톡시-4, 4 , 6 -트리메톡시-3 -(3-메틸-2-부테닐)칼콘, 2 , 4, 4 -트리히드록시칼콘, 2 -히드록시-4, 4 -디메톡시-3 -(3-메틸-2-부테닐)칼콘, 2 , 4, 4 , 6 -테트라히드록시-3 -(3-메틸-2-부테닐)칼콘, 2 -아세톡시-4, 4 , 6 -트리히드록시-3 -(3-메틸-2-부테닐)칼콘, 2 , 3, 4, 4 -테트라히드록시칼콘, 2 , 3, 4, 4 , 6 -펜타히드록시칼콘, 2 , 4, 4 , 6 -테트라히드록시-3 -이소펜틸칼콘, 1-(2, 4-디히드록시페닐)-3-(4-히드록시페닐)-1-프로판온, 1-(2, 4, 6-트리히드록시페닐)-3-(4-히드록시페닐)-1-프로판온,1-[2-아세톡시-4, 6-디히드록시-3-(3-메틸-2-부테닐)페닐]-3-(4-히드록시페닐)-1-프로판온, 1-[2, 4, 6-트리히드록시-3-(3-메틸-2-부테닐)페닐]-3-(4-히드록시페닐)-1-프로판온, 1-(2, 4, 6-트리히드록시-3-이소펜틸페닐)-3-(4-히드록시페닐)-1-프로판온, 1-(2, 4-디히드록시페닐)-3-(3, 4-디히드록시페닐)-1-프로판온, 1-(2, 4, 6-트리히드록시페닐)-3-(3, 4-디히드록시페닐)-1-프로판온, 1-(2-아세톡시-4, 6-디히드록시-3-이소펜틸페닐)-3-(4-히드록시페닐)-1-프로판온, 1-(2-히드록시-4, 6-디메톡시-3-이소펜탈페닐)-3-(4-메톡시페닐)-1-프로판온, 1-(4, 6-디히드록시-2-메톡시카르보닐메톡시-3-이소펜틸페닐)-3-(4-히드록시-페닐)-1-프로판온, 1-(2-카르복시메톡시-4, 6-디히드록시-3-이소펜틸페닐)-3-(4-히드록시페닐)-1-프로판온, 1-(2-히드록시-4-메톡시-3-이소펜틸페닐)-3-(4-메톡시페닐)-1-프로판온, 1-(3-이소펜틸-4, 6-디메톡시-2-메톡시카르보닐메톡시페닐)-3-(4-메톡시페닐)-1-프로판온, 1-(2-카르복시메톡시-4, 6-메톡시-3-이소펜틸페닐)-3-(4-메톡시페닐)-1-프로판온, 1-(2, 4-디히드록시-3-이소펜틸페닐)-3-(4-히드록시페닐)-1-프로판온, 및 1-(2, 4, 6-트리히드록시-3-이소펜틸페닐)-3-(4-히드록시-3-이소펜틸)-1-프로판온 중에서 화합물을 선택함을 특징으로 하는 항궤양제.
  3. 제2항에 있어서, 1-(2-카르복시메톡시-4-메톡시-3-이소펜틸페닐)-3-(4-메톡시페닐)-1-프로판온, 2 -카르복시메톡시-4-4 -디메톡시-3 -(3-메틸-2-부테닐)칼콘, 2 -카르복시메톡시-4, 4 , 6 -트리메톡시-3 -이소펜틸칼콘, 1-(2-카르복시메톡시-4, 6 -디메톡시페닐)-3-(4-메톡시페닐)-1-프로판온, 2 -카르복시메톡시-4, 4 , 6 -트리메톡시칼콘, 2 -카르복시메톡시-4, 4 , 6 -트리메톡시-3 -(3-메틸-2-부테닐)칼콘, 1-(2, 4-디히드록시페닐)-3-(3, 4-디히드록시페닐)-1-프로판온, 및 1-(2-카르복시메톡시-4, 6-디메톡시-3-이소펜틸페닐)-3-(4-메톡시페닐)-1-프로판온 중에서 화합물을 선택함을 특징으로 하는 항궤양제.
  4. 다음의 일반식(Ⅰ )으로 나타내는 화합물
    상기 일반식중, X' 및 Y' 는 각각 수소원자를 나타내거나 함께 결합을 형성하고, R'1은 히드록시기 또는 카르복시메톡시기를 나타내며 R'2는 수소원자, 이소프레닐기, 이소펜틸기 또는 프로필기를 나타내고, R'3은 히드록시기 또는 메톡시기를 나타내며, R'4는 수소원자, 히드록실기 또는 메톡시기를, R'5는 수소원자, 히드록실기, 메톡시기 또는 이소펜틸기, R'6은 히드록시기, 메톡시기 또는 카르복시메톡시기를 나타내고, R'7은 수소원자 또는 메톡시기를 나타내며, 만약 (1)R'2가 수소원자이며, R'4, R'4, R'5및 R'6중 적어도 하나는 메톡시기가 아니고, (2), R'2가 이소프레닐기이며, R' 1은 카르복시메톡시기이고, (3) R'2가 이소펜틸기이고 R'5와 R'7이 각각 수소원자이면, R' 는 수소원자이고, R'1및 R'6중 한가지는 카르복시메톡시기이며, (4) R'4가 수소원자가 아니면 R'3및 R'4는 일반적으로 히드록실기 또는 메톡시기를 나타내며, (5) R'5가 히드록실기이면, R'6은 메톡시기이고, (6) R' 가 에톡시기이면 R'6은 히드록실기이고, (7) R'6이 카르복시메톡시기이면 R'1은 히드록실기이다.
  5. 제4항에 있어서, 1-(2, 4, 6-트리-히드록시-3-이소펜틸페닐)-3-(4-히드록시-3-메톡시페닐)-1-프로판온, 1-(2, 4, 6-트리히드록시-3-이소펜틸-페닐)-3-(4-히드록시-3, 5-디메톡시페닐)-1-프로판온, 1-(2-카르복시메톡시-4-메톡시-3-이소펜틸페닐)-3-(4-메톡시페닐)-1-프로판온, 1-(2-히드록시-4-메톡시-3-이소펜틸페닐)-3-(4-카르복시메톡시페닐)-1-프로판온, 1-(2-카르복시메톡시-4, 6-디메톡시-3-이소펜틸페닐)-3-(4-히드록시-3-메톡시페닐)-1-프로판온, 1-(2-카르복시메톡시-4, 6-디메톡시-3-이소펜틸페닐)-3-(3-히드록시-4-메톡시페닐)-1-프로판온, 1-(2-카르복시메톡시-4, 6-디메톡시-3-이소펜틸페닐)-3-(4-히드록시-3, 5-디메톡시페닐)-1-프로판온, 2 -카르복시메톡시-4, 4 -디메톡시-3 -(3-메틸-2-부테닐)칼콘, 2 -카르복시메톡시-4, 4 , 6 -트리메톡시-3 -이소펜틸칼콘, 3-(4-히드록시-페닐)-1-(2, 4, 6-트리히드록시-3-n-프로필페닐)-1-프로판온, 1-(2-카르복시메톡시-4, 6-디메톡시페닐)-3-(4-메톡시페닐)-1-프로판온, 1-[2-카르복실메톡시-4, 6-디메톡시-3-(3-메틸-2-부테닐)페닐]-3-(4-메톡시페닐)-1-프로판온, 2 -카르복시메톡시-4, 4 , 6 -트리메톡시칼콘 및 2 -카르복시메톡시-4, 4 , 6 -트리메톡시-3 -(3-메틸-2-부테닐)칼콘 중에서 선택되는 화합물.
  6. 제5항에 있어서, 1-(2-카르복시메톡시-3-이소펜틸-4-메톡시페닐)-3-(4-메톡시페닐)-1-프로판온, 2 -카르복시메톡시-4, 4 -디메톡시-3 -(3-메틸-2-부테닐)칼콘, 2 -카르복시메톡시-4, 4 , 6 -트리메톡시-3-이소펜틸칼콘, 1-(2-카르복시메톡시-4, 6-디메톡시페닐)-3-(4-메톡시페닐)-1-프로판온, 2 -카르복시메톡시-4, 4 -트리메톡시칼콘 및 2 -카르복시메톡시-4, 4 , 6 -트리메톡시-3 -(3-메틸-2-부테닐)칼콘 중에서 선택되는 화합물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880700971A 1986-12-12 1987-12-12 유효성분으로서 칼콘 유도체를 함유하는 항 궤양제 및 신규의 칼콘 유도체 Withdrawn KR890700117A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP61-294952 1986-12-12
JP29495286A JPS63150241A (ja) 1986-12-12 1986-12-12 カルコン誘導体および該カルコン誘導体を有効成分とする抗潰瘍剤
JP19819787A JPS6442422A (en) 1987-08-10 1987-08-10 Antiulcer agent
JP62-198197 1987-08-10
PCT/JP1987/000973 WO1988004288A1 (en) 1986-12-12 1987-12-12 Anti-ulcerous agent containing chalcone derivative as effective ingredient and novel chalcone derivatives

Publications (1)

Publication Number Publication Date
KR890700117A true KR890700117A (ko) 1989-03-02

Family

ID=26510835

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880700971A Withdrawn KR890700117A (ko) 1986-12-12 1987-12-12 유효성분으로서 칼콘 유도체를 함유하는 항 궤양제 및 신규의 칼콘 유도체

Country Status (5)

Country Link
US (1) US5106871A (ko)
EP (1) EP0292576A4 (ko)
KR (1) KR890700117A (ko)
HU (1) HU203515B (ko)
WO (1) WO1988004288A1 (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234951A (en) * 1986-12-12 1993-08-10 Tsumura Juntendo, Inc. Anti-ulcer agent comprising chalcone derivative
CZ285937B6 (cs) * 1992-01-16 1999-12-15 Hoechst Aktiengesellschaft Arylcykloalkylové deriváty, způsob přípravy těchto derivátů a jejich použití
US5399584A (en) * 1992-05-05 1995-03-21 The Procter & Gamble Company Use of flavone derivatives for gastroprotection
DK99993D0 (da) * 1993-09-03 1993-09-03 Statens Seruminstitut Treatment and prophylaxis of diseases caused by parasites or bacteria
IT1271301B (it) * 1994-12-20 1997-05-27 Indena Spa Calconi naturali e sintetici e loro esteri ad attivita' antiproliferativa nei tumori dell'utero,dell'ovaio e del seno e formulazioni che li contengono
KR100447918B1 (ko) * 1996-07-25 2005-09-28 동아제약주식회사 대장을포함한위장관보호작용을갖는플라본및플라바논화합물
KR100270410B1 (ko) * 1997-03-06 2000-11-01 성재갑 타이로시네이즈 활성 저해능을 갖는 신규 1,3-디페닐프로판 유도체 및 그의 제조방법
KR100711537B1 (ko) * 2000-01-27 2007-04-27 다카라 바이오 가부시키가이샤 치료제
CA2714422A1 (en) * 2008-02-06 2009-08-13 Noscira, S.A. Phenyl-prenyl derivatives, of marine and synthetic origin, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders
CN102992988B (zh) * 2012-12-19 2015-06-17 苏薇薇 一种取代间苯三酚衍生物及其应用
JP6358877B2 (ja) * 2014-07-02 2018-07-18 株式会社Lジニン研究所 リキリチゲニン前駆物質の製造方法
CN106536468B (zh) * 2014-07-02 2020-07-28 肥后春男 甘草素前驱物质的制备方法
CN105693487B (zh) * 2016-01-26 2018-09-11 涟源康麓生物科技有限公司 一种利用柚子皮制备高纯度根皮素的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3137621A (en) * 1961-02-20 1964-06-16 Orsymonde Method of treating colic with trihydroxyacetophenones
FR95487E (fr) * 1967-07-26 1971-01-15 Rech S Ind Sori Soc D Nouveaux dérives flavoniques.
GB1283981A (en) * 1969-03-05 1972-08-02 Orsymonde 2,4,6-trihydroxy chalcone derivatives
US3743716A (en) * 1970-09-30 1973-07-03 Procter & Gamble Sweetening compositions containing aglyconic dihydrochalcones
JPS598249B2 (ja) * 1974-01-19 1984-02-23 大正製薬株式会社 カルコン類の合成法
JPS5912094B2 (ja) * 1974-01-19 1984-03-21 大正製薬株式会社 カルコン体の合成法
JPS5024257A (ko) * 1973-06-30 1975-03-15
JPS5911572B2 (ja) * 1973-10-30 1984-03-16 大正製薬株式会社 新規なイソプレニルカルコン類の合成法
CH593224A5 (ko) * 1973-10-30 1977-11-30 Taisho Pharmaceutical Co Ltd
JPS598251B2 (ja) * 1974-04-19 1984-02-23 大正製薬株式会社 イソプレニルカルコン類の合成法
JPS5419947A (en) * 1977-07-16 1979-02-15 Taisho Pharmaceut Co Ltd Chalcone derivatives
US4279930A (en) * 1978-10-10 1981-07-21 The Upjohn Company Process for treating inflammation
JPS5562044A (en) * 1978-11-01 1980-05-10 Taisho Pharmaceut Co Ltd Dihydrochalcone derivative
NZ192641A (en) * 1979-01-26 1984-10-19 Hoffmann La Roche Substituted acetophenones and pharmaceutical compositions
JP3110499B2 (ja) * 1991-06-04 2000-11-20 株式会社エルティーティー研究所 局所用気管支疾患治療剤

Also Published As

Publication number Publication date
US5106871A (en) 1992-04-21
WO1988004288A1 (en) 1988-06-16
HU203515B (en) 1991-08-28
EP0292576A1 (en) 1988-11-30
EP0292576A4 (en) 1990-10-03

Similar Documents

Publication Publication Date Title
KR890700117A (ko) 유효성분으로서 칼콘 유도체를 함유하는 항 궤양제 및 신규의 칼콘 유도체
KR830002827A (ko) 감작되어진 방향성의 요오드늄 또는 설포늄 화합물을 함유한 광중합성 조성물의 제조방법
KR850003400A (ko) 니트로메틸렌-테트라하이드로피리미딘 유도체의 제조방법
AR245994A1 (es) Composiciones reveladoras de haluro de plata fotograficos y procedimiento para la formacion de imagenes fotograficas de haluro de plata.
KR840001280A (ko) 탈취제 조성물
KR910009148A (ko) 페이스트형 살충제 조성물
KR840002363A (ko) 살충제조성물 및 그 제조방법
KR880011112A (ko) 벤즈아제핀 설폰아미드 화합물
JPS52113934A (en) Phenethylamine derivatives and bronchodilator containing the same
KR880009654A (ko) 아세트알데히드의 독성을 감소시키는 조성물 및 방법
KR840001543A (ko) 아스코크롤린 유도체의 제조
KR840009291A (ko) 비설파이트 및 알데히드 또는 케톤의 부가화합물의 조합에 의하여 안정화된 디니트로 아닐린 조성물
KR850002379A (ko) 피리다지논 유도체를 유효성분으로 하는 농약용 살균제
KR830005325A (ko) 수용성 화학 발광 시스템
KR830005168A (ko) 5-(디하이드록시페녹시)테트라졸의 제조방법
NO158016C (no) Fremgangsmaate for fremstilling av (-)-2-(1-(2,6-diklor-fenoksy)-etyl)-1,3-diazacyklopent-2-en.
DK210081A (da) 1-(3,5-bistrifluormethylphenyl)-3-(4-tert. butylpiperidino)-prop-1-yn eller syreadditionssalte deraf dets fremstilling og anvendelse som rodenticid
KR900701262A (ko) 췌장염 등에 대한 치료제
KR840006901A (ko) 살균 조성물
KR920001242A (ko) 포지티브 레지스트 조성물
KR830006257A (ko) 페닐 피페라진 유도체의 제조방법
KR910006779A (ko) 감방사선성 포지티브 레지스트 조성물
US2391552A (en) Stabilized aromatic compounds
KR850001663A (ko) 살충 및 응애류 박멸제 조성물
KR830000690A (ko) 제초 제1-알킬-3-페닐피리디늄 염

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19880812

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid